Authors: von Eynatten, Maximilian; Humpert, Per M

Source: Expert Review of Molecular Diagnostics, Volume 8, Number 3, May 2008 , pp. 289-299(11)

Publisher: Expert Reviews

Abstract:

Retinol-binding protein-4 (RBP4), a 21-kDa protein synthesized in the liver and adipose tissue, has recently been described as a murine adipokine involved in the development of insulin resistance. The expression of the gene encoding RBP4 was increased in the adipose tissue, but not in the liver, of insulin-resistant adipose GLUT4^-/- mice and five other mouse models of obesity and insulin resistance. In addition, intraperitoneal injection or transgenic overexpression of RBP4 in mice induced insulin resistance. While experimental clinical approaches (mostly applying clamp techniques) in humans confirmed correlations of RBP4 with insulin resistance, studies in larger groups out of clinical routine failed to demonstrate a connection with alternative measures of insulin sensitivity. Yet, significant associations of RBP4 with atherogenic lipids were found and a focus of future studies should be the influence on atherosclerosis and related complications. Based on current data, the function of RBP4 as an adipokine exerting metabolic effects in glucose metabolism in humans remains uncertain and might be restricted to rodent models.

Keywords: adipokine; coronary artery; dyslipidemia disease; insulin sensitivity; metabolic syndrome; obesity; retinol-binding protein-4; Type 2 diabetes

Document Type: Research article

DOI: http://dx.doi.org/10.1586/14737159.8.3.289

Affiliations: 1: Department of Nephrology, Technical University Munich, Ismaningerstr. 22, 81675 Munich, Germany., Email: maximilian.eynatten@lrz.tum.de

Publication date: 2008-05-01

More about this publication?

• Expert Review of Molecular Diagnostics provides expert reviews on molecular diagnostic technologies and applied pharmacogenomics in clinical medicine. Coverage includes molecular diagnostics, biomarkers, diagnostic technologies, microarrays and biochips, proteomics, pharmacogenomics, pharmacogenetics and personalized medicine.
• Editorial Board
• Information for Authors
• Submit a Paper
• Subscribe to this Title
• Information for Advertisers
• Terms & Conditions
• Information for Librarians
• Free Trials
• ingentaconnect is not responsible for the content or availability of external websites

Related content

• In this: publication
• By this: publisher
• In this Subject: Biology ,  Genetics
• By this author: von Eynatten, Maximilian ;  Humpert, Per M

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers